NON INVASIVE PRENATAL DIAGNOSIS OF ANEUPLOIDY:
NEXT GENERATION SEQUENCING OR FETAL DNA
ENRICHMENT?
Webb A, Madgett TE, Miran T, Sillence K, Kaushik N, Kiernan M, Avent ND*
*Corresponding Author: Professor Neil D. Avent, School of Biomedical and Biological Sciences, Faculty of
Science and Technology, A411 Portland Square, Drake Circus, Plymouth, Devon, PL4 8AA, UK; Tel.: +44-
(0)1752-584884; Fax: +44-(0)1752-584605; E-mail: neil.avent@plymouth.ac.uk
page: 17
|
|
REFERENCES
1. NHS FASP, 2010. NHS Fetal Anomaly Screening
Programme Annual Report 2009-2010. Available
at [http://fetalanomaly.screening.nhs.uk/getdata.
php?id=11354] Accessed on January 16 2012.
2. Mujezinovic F, Alfirevic Z. Procedure-related complications
of amniocentesis and chorionic villous
sampling. Obstet Gynecol. 2007; 110(3): 687-694.
3. Go AT, van Vugt JMG, Oudejans CBM. Non invasive aneuploidy detection using free fetal DNA
and RNA in maternal plasma: recent progress and future
possibilities. Hum Reprod Update. 2011; 17(3):
372-382.
4. Hahn S, Lapaire O, Tercanli S, Kolla V, Hösli I. 2011.
Determination of fetal chromosome aberrations from
fetal DNA in maternal blood: has the challenge finally
been met? Expert Rev Molec Med. 2011; 13; 16:
e16. Available at [http://www.ncbi.nlm.nih.gov/pmc/
articles/ PMC3087311/pdf/S1462399411001852a.
pdf] Accessed on January 16 2012.
5. Nicolaides KH. Screening for fetal aneuploidies at
11 to 13 weeks. Prenat Diagn. 2011; 31(1): 7-15.
6. NHS, 2010. When an abortion should be carried
out. Available at [http://www.nhs.uk/Conditions/
Abortion/ Pages/When-should-it-be-done.aspx]
Accessed on January 8 2012.
7. Bischoff FZ, Sinacori MK, Dang DD, et al. Cell-free
fetal DNA and intact fetal cells in maternal blood
circulation: implications for first and second trimester
non-invasive prenatal diagnosis. Hum Reprod
Update. 2001; 8(6): 493-500.
8. Chitty LS, van der Schoot CE, Hahn S, Avent ND.
SAFE–The special non-invasive advances in fetal
and neonatal evaluation network: aims and achievements.
Prenat Diagn. 2009; 28(2): 83-88.
9. Maddocks DG, Alberry MS, Attilakos G, et al. The
SAFE project–towards non-invasive prenatal diagnosis.
Biochem Soc Transactions. 2009; 37: 460-465.
10. Lo YMD, Corbetta N, Chamberlain PF, et al.
Presence of fetal DNA in maternal plasma and serum.
Lancet 1997; 350(9076): 485-487.
11. Lo YMD. Non-invasive prenatal diagnosis using
fetal cells in maternal blood. J Clin Pathol. 1994;
47(12): 1060-1065.
12. Herzenburg LA, Bianchi DW, Schroder J, Cann HM,
Iverson GM. Fetal cells in the blood of pregnant
women: Detection and enrichment by fluorescenceactivated
cell sorting. Proc Natl Acad Sci USA.
1979; 76(3): 1453-1455.
13. Avent ND, Plummer ZE, Madgett TE, et al. Postgenomics
studies and their application to non-invasive
prenatal diagnosis. Semin Fetal Neonat Med.
2008; 13: 91-98.
14. Wapner RJ. Invasive prenatal diagnostic techniques.
Semin Perinatol. 2005; 29(6): 401-404.
15. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S,
DeMaria MA. Male fetal progenitor cells persist in
maternal blood for as long as 27 years postpartum.
Proc Natl Acad Sci USA. 1996; 93(2): 705-708.
16. Illanes S, Denbow M, Kailasam C, Finning K,
Soothill PW. Early detection of cell-free fetal DNA
in maternal plasma. Early Hum Dev. 2007; 83(9):
563-566.
17. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM,
Hjelm NM. Rapid clearance of fetal DNA from maternal
plasma. Am J Hum Genet. 1999; 64(1): 218-224.
18. Avent ND, Finning KM, Martin PG, Soothill PW.
Prenatal determination of fetal blood group status.
Vox Sang. 2000; 78(2): 155-162.
19. Finning KM, Martin PG, Soothill PW, Avent ND.
Prediction of fetal D status from maternal plasma: introduction
of a new noninvasive fetal RHD genotyping
service. Transfusion. 2002; 42(8): 1079-1085.
20. Scheffer PG, van der Schoot CE, Page-Christiaens
GCML, de Haas M. Noninvasive fetal blood group
genotyping of rhesus D, c, E and of K in alloimmunised
pregnant women: evaluation of a 7 year clinical
experience; Br J Obstet Gynaecol. 2011; 118(11):
1340-1348.
21. Avent ND, Chitty LS. Non-invasive diagnosis of fetal
sex; utilisation of free fetal DNA in maternal plasma
and ultrasound. Prenat Diagn. 2006; 26(7): 598-603.
22. Poon LLM, Leung TN, Lau TK, Chow KCK, Lo
YMD. Differential DNA methylation between fetus
and mother as a strategy for detecting fetal DNA in
maternal plasma. Clin Chem. 2002; 48(1): 35-41.
23. Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous
and added RNA in blood specimens, serum,
and plasma. Clin Chem. 2002; 48(10): 1647-1653.
24. Chiu RW, Lui WB, Cheung MC. et al. Time profile
of appearance and disappearance of circulating
placenta-derived mRNA in maternal plasma. Clin
Chem. 2006; 52(2): 313-316.
25. Ng EKO, Tsui NBY, Lau TK, et al. mRNA of placental
origin is readily detectable in maternal plasma.
Proc Natl Acad Sci USA. 2003; 100(8): 4748-4753.
26. Lo YMD, Tsui NBY, Chiu RWK, et al. Plasma placental
RNA allelic ratio permits noninvasive prenatal
chromosomal aneuploidy detection. Nat Med. 2007;
13(2): 218-223.
27. Lo YMD. Noninvasive prenatal detection of fetal
chromosomal aneuploidies by maternal plasma nucleic
acid analysis: a review of the current state of
the art. Br J Obstet Gynaecol. 2008; 116(2): 152-157.
28. Lo YMD, Lun FMF, Chan KCA, et al. Digital PCR
for the molecular detection of fetal chromosomal aneuploidy.
Proc Natl Acad Sci USA. 2007; 104(32):
13116-13121.
29. Chim SSC, Tong YK, Chiu RWK, et al. Detection of
the placental epigenetic signature of the maspin gene
in maternal plasma. Proc Natl Acad Sci USA. 2005;
102(41): 14753-14758.
30. Tong YK, Ding C, Chiu RWK, et al. Noninvasive
prenatal detection of fetal trisomy 18 by epigenetic
allelic ratio analysis in maternal plasma: theoretical
and empirical considerations. Clin Chem. 2006;
52(12): 2194-2202.
31. Weber M, Davies JJ, Wittig D, et al. Chromosomewide
and promoter-specific analyses identify sites of
differential DNA methylation in normal and transformed
human cells. Nat Genet. 2005; 37(8): 853-62.
32. Papageorgiou EA, Fiegler H, Rakyan V, et al. Sites
of Differential DNA Methylation between Placenta
and Peripheral Blood: Molecular Markers for
Noninvasive Prenatal Diagnosis of Aneuploidies.
Am J Pathol. 2009; 174(5): 1609-1618.
33. Lun FMF, Chiu RWK, Chan KCA, et al. Microfluidics
digital PCR reveals a higher than expected fraction
of fetal DNA in maternal plasma. Clin Chem. 2008;
54(10): 1664-1672.
34. Tong YK, Jin S, Chiu RWK, et al. Noninvasive prenatal
detection of trisomy 21 by an epigenetic-genetic
chromosome-dosage approach. Clin Chem. 2010;
56(1): 90-98.
35. Tsui DWY, Lam YMD, Lee WS, et al. Systematic
identification of placental epigenetic signatures for
the noninvasive prenatal detection of Edward’s syndrome.
PLoS One 2010; 5(11): e15069.
36. Vogelstein B, Kinzler KW. 1999. Digital PCR. Proc
Natl Acad Sci USA. 1999; 96(16): 9236-9241.
37. Zimmermann BG, Grill S, Holzgreve W, et al.
Digital PCR: a powerful new tool for noninvasive
prenatal diagnosis? Prenat Diagn. 2008; 28(12):
1087-1093.
38. Fan HC, Quake SR. Detection of aneuploidy with
digital polymerase chain reaction. Anal Chem. 2007;
79(19): 7576-7579.
39. Fan HC, Blumenfeld YJ, Chitkara U, et al.
Noninvasive diagnosis of fetal aneuploidy by shotgun
sequencing DNA from maternal blood. Proc
Natl Acad Sci USA. 2008; 105(42): 16266-16271.
40. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal
diagnosis of fetal trisomy 18 and trisomy 13 by
maternal plasma DNA sequencing. PLoS One 2011;
6(7): e21791.
41. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive
detection of fetal trisomy 21 by sequencing of DNA
in maternal blood: a study in a clinical setting. Am J
Obstet Gynecol. 2011; 204(3): 205.e1-11.
42. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive
prenatal diagnosis of fetal chromosomal aneuploidy
by massively parallel genomic sequencing of DNA
in maternal plasma. Proc Natl Acad Sci USA. 2008;
105(51): 20458-20463.
43. van den Oever JM, Balkassmi S, Verweij EJ, et al.
Single molecule sequencing of free DNA from maternal
plasma for noninvasive trisomy 21 detection.
Clin Chem. 2012; 58(4): 699-706.
44. Avent ND. Refining noninvasive prenatal diagnosis
with single-molecule next generation sequencing.
Clin Chem. 2012; 58(4): 657-658.
45. Dhallan R, Au WC, Mattagajasingh S, et al. Methods
to increase the percentage of free fetal DNA recovered
from the maternal circulation. JAMA. 2004;
291(9): 1114-1119.
46. Chung GTY, Chiu RWK, Chan KCA, et al. Lack of
dramatic enrichment of fetal DNA in maternal plasma
by formaldehyde treatment. Clin Chem. 2005;
51(3): 655-658.
47. Chinnapapagari SKR, Holzgreve W, Lapaire O, et al.
Treatment of maternal blood samples with formaldehyde
does not alter the proportion of circulatory fetal
nucleic acid (DNA and RNA) in maternal plasma.
Clin Chem. 2005; 51(3): 652-655.
48. Li Y, Zimmermann B, Rusterholz C, et al. Size separation
of circulatory DNA in maternal plasma permits
ready detection of fetal DNA polymorphisms.
Clin Chem. 2004; 50(6): 1002-1011.
49. Chan KCA, Zhang J, Hui ABY, et al. Size distributions
of maternal and fetal DNA in maternal plasma.
Clin Chem. 2004; 50(1): 88-92.
50. Li Y, Di Naro E, Vitucci A, et al. Detection of paternally
inherited fetal point mutations for b-thalassemia
using size-fractionated cell-free DNA in maternal
plasma. JAMA. 2005; 293(7): 843-849.
51. Li J, Wang L, Mamon H, et al. Replacing PCR with
COLD-PCR enriches variant DNA sequences and
redefines the sensitivity of genetic testing. Nat Med.
2008; 14(5): 579-584.
52. Li J, Makrigiorgos GM. COLD-PCR: a new platform
for highly improved mutation detection in cancer
and genetic testing. Biochem Soc Transactions.
2009; 37(2): 427-432.
53. Kolialexi A, Tsangaris GT, Papantoniou N, et al.
Application of proteomics for the identification of
differentially expressed protein markers for Down
syndrome in maternal plasma. Prenat Diagn. 2008;
28(8): 691-698.
54. Choolani M, Narasimkhan K, Kolla V, Hahn S.
Proteomic technologies for prenatal diagnostics: advances
and challenges ahead. Expert Rev Proteomics.
2009; 6: 87-101.
55. Tsangaris GT, Karamessinis P, Kolialexi A, et al.
Proteomic analysis of amniotic fluid in pregnancies
with Down syndrome. Proteomics. 2006; 6(15):
4410-4419.
56. Nagalla SR, Canick JA, Jacob T, et al. Proteomic
analysis of maternal serum in Down syndrome: identification
of novel protein biomarkers. J Proteome
Res. 2007; 6: 1245-1257.
57. Kolla V, Jenö P, Moes S, et al. Quantitative proteomics
analysis of maternal plasma in Down syndrome
pregnancies using isobaric tagging reagent
(iTRAQ). J Biomed Biotechnol. 2010; 2010: 952047
[Epub 2009 Nov 5].
58. Heywood WE, Madgett TE, Wang D, et al. 2D-DIGE
analysis of maternal plasma for potential biomarkers
for Down syndrome. Proteome Sci. 2011; 9: 56.
59. Heywood WE, Mills K, Wang D, et al. Identification
of new biomarkers for Down’s syndrome in maternal plasma. J Proteomics. 2012; in press.
60. Heywood WE, Wang D, Madgett TE, et al. The development
of a peptide -SRM based tandem mass
spectrometry assay for prenatal screening of Down
syndrome. J Proteomics. 2012; in press.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
